2013 American Transplant Congress
Incidence of CMV Disease in High-Risk Liver Transplant Recipients on Low Dose Valganciclovir Prophylaxis
Background: CMV serostatus D+/R- is an important risk factor for developing CMV infection post-transplant. Although CMV anti-viral prophylaxis (ppx) has reduced the incidence of CMV…2013 American Transplant Congress
Donor Evaluation Efficiency Issues in Kidney Paired Donation: Increased Evaluations, Turn Downs, Time to Donation and Cost
Introduction Kidney paired donation (KPD) is critically dependent on the availability of a large number of willing and acceptable donors. Accepting a large number of…2013 American Transplant Congress
Pre Liver Transplant Loco Regional Bridging Therapy for HCC: Efficacy of Combined TACE and RFA Versus TACE Alone Based on Explant Pathology
Aim: to compare efficacy of combined transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) versus TACE alone in pre transplant treatment of hepatocellular carcinoma (HCC) based…2013 American Transplant Congress
Eculizumab in aHUS Pts with Long Disease Duration, with or without Renal Transplant
INTRODUCTION: aHUS is marked by uncontrolled complement activation and TMA. Eculizumab (ecu), approved for aHUS, selectively inhibits terminal complement activation. Ongoing aHUS following renal transplant…2013 American Transplant Congress
Post Transplant Lymphoproliferative Disorders: Clinicopathological Analysis of 54 Cases in a Single Center
Introduction:A post transplant lymphoproliferative disorder (PTLD) is an infrequent but serious complication following solid organ transplantation. The incidence varies and depends on the type of…2013 American Transplant Congress
Polyoma Viremia Adversely Affects Renal Function at One Year in Kidney Transplant Recipients: Independent of Immunosuppressive Regimen
Div. Transplantation/Surgery, University of California, Irvine School of Medicine, Orange, Ca.
Background:Polyoma virus (BKV) reactivation is a complication in renal transplant recipients that can lead to BKV nephropathy (BKVN) and allograft loss.The purpose of this study…2013 American Transplant Congress
Effect of Pretransplant Renal Replacement Therapy on Liver Transplant Outcomes
Aim: To evaluate outcomes of cirrhotic patients who received renal replacement therapy prior to liver transplant.Methods: A retrospective review of cirrhotic patients who received orthotopic…2013 American Transplant Congress
Identifying the Most Dangerous DSA: A 12-Year Longitudinal Post-Transplant Study of IgM, IgG, and IgG Isotype HLA Alloantibodies in Primary Renal Transplant Recipients
Due to the lack of longitudinal serum collection in transplant patients, the natural history of the humoral response is undocumented and may reveal why many…2013 American Transplant Congress
Impact of Donor Hypoxemia and Hypotension in DCD Liver Transplantation
Medstar Georgetown University Hospital, Washington, DC
Aim: Donation after cardiac death (DCD) is a valuable source of liver grafts Little is known about the impact of severe hypoxemia and hypotension before…2013 American Transplant Congress
Incorporating Time from Donation (TFD) to the MDRD and CKD-EPI Formulas Enhances Their Performance in Kidney Donors
Introduction:The reexpressed MDRD study equation is least biased in estimating GFR in former kidney donors. Hyperfiltration is not limited to the first year after donation.…
American Transplant Congress abstracts